Corrado Ficorella - Concepedia

Author

Corrado Ficorella

Also Known As

C FICORELLA, C Ficorella, C. Ficorella, CORRADO FICORELLA, Corrado FICORELLA, Corrado Ficorella, Corrado Ficorella,, Ficorella C, Ficorella Corrado, Gabriella Moretti

451

Publications

6.9K

Citations

H-Index

144

Concepts

All Affiliations

University of L'Aquila San Salvatore Hospital University of Chieti-Pescara Sapienza University of Rome Istituti di Ricovero e Cura a Carattere Scientifico

About

Corrado Ficorella is an author at University of L'Aquila specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	53	2.4K
2	Health Sciences	11	13	746
3	Nursing	4	4	327
4	Engineering	1	1	12
5	Social Sciences	1	1	20

Corrado Ficorella

120

Publications

5.8K

Citations

H-Index

Page 1

	Year	Citations
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable Alessio Cortellini, Melissa Bersanelli, Sebastiano Buti, Journal for ImmunoTherapy of Cancer	2019	400
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice Alessio Cortellini, Marco Tucci, Vincenzo Adamo, Journal for ImmunoTherapy of Cancer	2020	250
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study Alessio Cortellini, Sebastiano Buti, Daniele Santini, The Oncologist ImmunologyImmunoeditingPathologyAnti-programmed Death-1 ImmunotherapyImmunotherapy	2019	214
Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis Giuseppe Di Lorenzo, Riccardo Autorino, Gianni Bruni, Annals of Oncology	2009	204
Correlations Between the Immune-related Adverse Events Spectrum and Efficacy of Anti-PD1 Immunotherapy in NSCLC Patients Alessio Cortellini, Rita Chiari, Biagio Ricciuti, Clinical Lung Cancer Cancer ImmunosurveillanceAnti-pd1 ImmunotherapyImmunodeficienciesImmunologyClinical Trials	2019	174
Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer Francesco Baudi, Barbara Quaresima, Cristina Grandinetti, Human Mutation	2001	143
Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients Silvio Romano, Simona Fratini, Enrico Ricevuto, British Journal of Cancer	2011	142
Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer Giuseppe Di Lorenzo, Giacomo Cartenì, Riccardo Autorino, Journal of Clinical Oncology	2009	134
Sustained‐release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management Sebastiano Mercadante, Giampiero Porzio, Patrizia Ferrera, European Journal of Pain	2008	132
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy Alessio Cortellini, Massimo Di Maïo, Olga Nigro, Journal for ImmunoTherapy of Cancer	2021	132

Page 1